The TRIM24‐based PROTAC (dTRIM24) was reported to drive potent and selective degradation of TRIM24 by recruiting VHL E3, resulting in inhibition of cell proliferation in acute leukemia cells. Here, TRIM24 is linked to acute leukemia.